Charles River Associates (CRAI) Q4 2025 earnings review
Top-Line Records Mask Emerging Cash Flow and Margin Pressures
Charles River Associates delivered its eighth consecutive year of record revenue, with Q4 sales accelerating to 11.6% YoY growth. However, this impressive top-line momentum did not translate to the bottom line in the final quarter. Q4 GAAP Net Income fell 12.0% YoY, and EBITDA margins contracted as the company heavily subsidized talent acquisition. A massive $87.9 million in forgivable loan advances in FY25 effectively halved Operating Cash Flow despite record reported earnings, signaling that the cost of top-tier consulting talent is inflating rapidly.
🐂 Bull Case
Revenue growth is accelerating, jumping from 5.9% in Q1 to 11.6% in Q4. Four major practices (Antitrust & Competition, Energy, Forensic Services, and Labor & Employment) posted double-digit growth, proving resilience across multiple consulting verticals.
Utilization remained exceptionally strong at 78% in Q4 (up from 77% in Q3). Simultaneously, the company successfully grew its quarter-end consultant headcount by 1.4% YoY, ensuring capacity to capture ongoing demand.
🐻 Bear Case
Despite FY25 Net Income growing 17.4%, GAAP Operating Cash Flow collapsed by 55% YoY (from $49.7M to $22.4M). This severe red flag is entirely driven by upfront cash outlays to attract and retain talent.
Q4 Non-GAAP EBITDA was completely flat YoY at $24.4 million despite $20.5 million in additional revenue. Margin compressed by 150 basis points from 13.9% to 12.4%, indicating negative operating leverage as compensation and reimbursable costs rise.
⚖️ Verdict: ⚪
Neutral. The sheer consistency of CRA's top-line revenue growth and high utilization is commendable. However, the aggressive use of forgivable loans to secure talent is draining cash and creating an amortization headwind that will cap margin expansion in FY26.
Key Themes
The Hidden Cost of Talent: Forgivable Loans Ravaging Cash Flow
The most striking data point in the financials is the massive spike in talent acquisition costs. 'Forgivable loan advances' skyrocketed to $87.9 million in FY25, nearly double the $45.5 million spent in FY24. Because these cash advances are amortized over time, they artificially inflate current GAAP earnings while devastating actual cash generation. This forced CRA to tap its revolving line of credit for $34 million by year-end to bridge the cash gap. Management explicitly guided that the non-cash amortization of these loans will increase by ~$15 million (>30% YoY) in FY26, creating a direct headwind to future profitability.
International Expansion Paying Off
While North American operations grew a healthy 9.4% YoY in Q4, international revenue accelerated aggressively, jumping 21.9%. This geographic diversification helps insulate the firm from localized macro shocks and proves the portability of its core Antitrust and Forensics practices across jurisdictions.
Calendar Shift Headwind in FY26
Investors should note that FY25 benefited from a 53-week calendar year (including a 14-week Q4). FY26 will revert to a standard 52-week year. This creates a difficult YoY comparable for revenue and billable hours, making the firm's guidance of continued top-line growth more demanding to execute.
Shareholder Returns Shift to Debt-Funded Buybacks
CRA aggressively returned capital in FY25, executing $47.1 million in share repurchases and paying $13.8 million in dividends. The Board just authorized another $55 million buyback expansion. However, with free cash flow heavily constrained by forgivable talent loans, the firm ended the year with $34 million drawn on its revolver—meaning current buybacks are essentially being funded by debt rather than organic cash flow.
Other KPIs
Stable compared to 78% in 24Q4, and tracking well above the 75% average seen in FY24. This confirms that the recent headcount additions are being deployed efficiently onto billable client work, avoiding bench-time bloat.
Accelerating. Q4 SG&A rose to 17.1% of revenue, up from 16.1% excluding commissions. This uptick in overhead highlights the structural margin pressure the company faces beyond just direct consultant compensation.
Slightly decelerating (worsening) from 106 days a year ago. It consists of 78 days billed and 30 days unbilled. Unbilled DSO remains flat, showing standard project progression, but billed collections have slowed slightly by 2 days.
Guidance
Decelerating. This midpoint implies roughly 5.8% YoY growth, a step down from the 9.3% growth achieved in FY25. The deceleration is partially attributable to the loss of the 53rd week, alongside an expected $5 million FX headwind.
Stable to slightly declining compared to the 12.9% achieved in FY25. The guided $15 million increase in forgivable loan amortization will act as a primary anchor on margin expansion, offsetting the benefits of continued revenue growth.
Key Questions
Sustainability of Talent Bidding Wars
Forgivable loan advances nearly doubled to $88 million this year, destroying operating cash flow. Is this level of upfront cash outlay the 'new normal' for acquiring senior talent, or was FY25 an anomaly?
Margin Walk for FY26
With forgivable loan amortization expected to add a $15 million headwind next year, what specific operational efficiencies or pricing actions will you take to maintain EBITDA margins in the 12-13% guided range?
Capital Allocation and Leverage
With the authorization of a new $55 million buyback program and OCF pressured by talent advances, are you comfortable expanding the balance on the revolving credit facility to fund these repurchases?
Impact of 53rd Week
Can you quantify the exact revenue and EBITDA contribution of the extra 14th week in Q4 2025 to give investors a clearer organic baseline heading into a 52-week FY26?